Fresenius Kabi Pharmaceuticals (APCVZ)

[sigma_x]

Alright - So What's the Deal Here? Is it for Fresenius or is it for APP's CVR's that sales of these two drugs will presumably show up as adjusted EBTIDA? I saw several posts on both Yahoo and here stating that it's Fresenius Oncology that will reap the fruits of these two drugs. But, until I see differently, it's still conjecture. I'm only a penny off my buy-in price, and I still say this thing gets one more run before Dec. 31st if for no other reason that it'll give the MM's another opportunity to short it back down to zero.

But, still, I'd like to know for sure whether these two drugs were tentatively approved as part of APP or FK oncology?

It should be pretty simple to find out - was there a PR listed under the stock symbol on the Bombay Stock Exchange it trades on?